This report contains market size and forecasts of Oncology Drugs in Global, including the following market information:
Global Oncology Drugs Market Revenue, 2016-2021, 2022-2027, ($ millions)
Global top five companies in 2020 (%)
The global Oncology Drugs market was valued at 183760 million in 2020 and is projected to reach US$ 267650 million by 2027, at a CAGR of 9.9% during the forecast period.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Oncology Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Oncology Drugs Market, By Type, 2016-2021, 2022-2027 ($ millions)
Global Oncology Drugs Market Segment Percentages, By Type, 2020 (%)
Chemotherapy
Targeted Therapy
Immunotherapy (Biologic Therapy)
Hormonal Therapy
Others
China Oncology Drugs Market, By Application, 2016-2021, 2022-2027 ($ millions)
China Oncology Drugs Market Segment Percentages, By Application, 2020 (%)
Blood Cancer
Breast Cancer
Gastrointestinal Cancer
Prostate Cancer
Respiratory or Lung Cancer
Others
Global Oncology Drugs Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions)
Global Oncology Drugs Market Segment Percentages, By Region and Country, 2020 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Total Oncology Drugs Market Competitors Revenues in Global, by Players 2016-2021 (Estimated), ($ millions)
Total Oncology Drugs Market Competitors Revenues Share in Global, by Players 2020 (%)
Further, the report presents profiles of competitors in the market, including the following:
Roche
Celgene
Novartis
Bristol-Myers Squibb
Johnson & Johnson
Merck & Co.
AstraZeneca
Pfizer
Amgen
Eli Lilly
AbbVie
Takeda
Astellas
Ipsen
Sanofi
Bayer
Biogen Idec
Teva
Otsuka
Eisai
Merck KGaA
Gilead Sciences
Table of Contents
1 Introduction to Research & Analysis Reports
1.1 Oncology Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Oncology Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Oncology Drugs Overall Market Size
2.1 Global Oncology Drugs Market Size: 2021 VS 2027
2.2 Global Oncology Drugs Market Size, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Oncology Drugs Players in Global Market
3.2 Top Global Oncology Drugs Companies Ranked by Revenue
3.3 Global Oncology Drugs Revenue by Companies
3.4 Top 3 and Top 5 Oncology Drugs Companies in Global Market, by Revenue in 2020
3.5 Global Companies Oncology Drugs Product Type
3.6 Tier 1, Tier 2 and Tier 3 Oncology Drugs Players in Global Market
3.6.1 List of Global Tier 1 Oncology Drugs Companies
3.6.2 List of Global Tier 2 and Tier 3 Oncology Drugs Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Oncology Drugs Market Size Markets, 2021 & 2027
4.1.2 Chemotherapy
4.1.3 Targeted Therapy
4.1.4 Immunotherapy (Biologic Therapy)
4.1.5 Hormonal Therapy
4.1.6 Others
4.2 By Type - Global Oncology Drugs Revenue & Forecasts
4.2.1 By Type - Global Oncology Drugs Revenue, 2016-2021
4.2.2 By Type - Global Oncology Drugs Revenue, 2022-2027
4.2.3 By Type - Global Oncology Drugs Revenue Market Share, 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Oncology Drugs Market Size, 2021 & 2027
5.1.2 Blood Cancer
5.1.3 Breast Cancer
5.1.4 Gastrointestinal Cancer
5.1.5 Prostate Cancer
5.1.6 Respiratory or Lung Cancer
5.1.7 Others
5.2 By Application - Global Oncology Drugs Revenue & Forecasts
5.2.1 By Application - Global Oncology Drugs Revenue, 2016-2021
5.2.2 By Application - Global Oncology Drugs Revenue, 2022-2027
5.2.3 By Application - Global Oncology Drugs Revenue Market Share, 2016-2027
6 Sights by Region
6.1 By Region - Global Oncology Drugs Market Size, 2021 & 2027
6.2 By Region - Global Oncology Drugs Revenue & Forecasts
6.2.1 By Region - Global Oncology Drugs Revenue, 2016-2021
6.2.2 By Region - Global Oncology Drugs Revenue, 2022-2027
6.2.3 By Region - Global Oncology Drugs Revenue Market Share, 2016-2027
6.3 North America
6.3.1 By Country - North America Oncology Drugs Revenue, 2016-2027
6.3.2 US Oncology Drugs Market Size, 2016-2027
6.3.3 Canada Oncology Drugs Market Size, 2016-2027
6.3.4 Mexico Oncology Drugs Market Size, 2016-2027
6.4 Europe
6.4.1 By Country - Europe Oncology Drugs Revenue, 2016-2027
6.4.2 Germany Oncology Drugs Market Size, 2016-2027
6.4.3 France Oncology Drugs Market Size, 2016-2027
6.4.4 U.K. Oncology Drugs Market Size, 2016-2027
6.4.5 Italy Oncology Drugs Market Size, 2016-2027
6.4.6 Russia Oncology Drugs Market Size, 2016-2027
6.4.7 Nordic Countries Oncology Drugs Market Size, 2016-2027
6.4.8 Benelux Oncology Drugs Market Size, 2016-2027
6.5 Asia
6.5.1 By Region - Asia Oncology Drugs Revenue, 2016-2027
6.5.2 China Oncology Drugs Market Size, 2016-2027
6.5.3 Japan Oncology Drugs Market Size, 2016-2027
6.5.4 South Korea Oncology Drugs Market Size, 2016-2027
6.5.5 Southeast Asia Oncology Drugs Market Size, 2016-2027
6.5.6 India Oncology Drugs Market Size, 2016-2027
6.6 South America
6.6.1 By Country - South America Oncology Drugs Revenue, 2016-2027
6.6.2 Brazil Oncology Drugs Market Size, 2016-2027
6.6.3 Argentina Oncology Drugs Market Size, 2016-2027
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Oncology Drugs Revenue, 2016-2027
6.7.2 Turkey Oncology Drugs Market Size, 2016-2027
6.7.3 Israel Oncology Drugs Market Size, 2016-2027
6.7.4 Saudi Arabia Oncology Drugs Market Size, 2016-2027
6.7.5 UAE Oncology Drugs Market Size, 2016-2027
7 Players Profiles
7.1 Roche
7.1.1 Roche Corporate Summary
7.1.2 Roche Business Overview
7.1.3 Roche Oncology Drugs Major Product Offerings
7.1.4 Roche Oncology Drugs Revenue in Global (2016-2021)
7.1.5 Roche Key News
7.2 Celgene
7.2.1 Celgene Corporate Summary
7.2.2 Celgene Business Overview
7.2.3 Celgene Oncology Drugs Major Product Offerings
7.2.4 Celgene Oncology Drugs Revenue in Global (2016-2021)
7.2.5 Celgene Key News
7.3 Novartis
7.3.1 Novartis Corporate Summary
7.3.2 Novartis Business Overview
7.3.3 Novartis Oncology Drugs Major Product Offerings
7.3.4 Novartis Oncology Drugs Revenue in Global (2016-2021)
7.3.5 Novartis Key News
7.4 Bristol-Myers Squibb
7.4.1 Bristol-Myers Squibb Corporate Summary
7.4.2 Bristol-Myers Squibb Business Overview
7.4.3 Bristol-Myers Squibb Oncology Drugs Major Product Offerings
7.4.4 Bristol-Myers Squibb Oncology Drugs Revenue in Global (2016-2021)
7.4.5 Bristol-Myers Squibb Key News
7.5 Johnson & Johnson
7.5.1 Johnson & Johnson Corporate Summary
7.5.2 Johnson & Johnson Business Overview
7.5.3 Johnson & Johnson Oncology Drugs Major Product Offerings
7.5.4 Johnson & Johnson Oncology Drugs Revenue in Global (2016-2021)
7.5.5 Johnson & Johnson Key News
7.6 Merck & Co.
7.6.1 Merck & Co. Corporate Summary
7.6.2 Merck & Co. Business Overview
7.6.3 Merck & Co. Oncology Drugs Major Product Offerings
7.6.4 Merck & Co. Oncology Drugs Revenue in Global (2016-2021)
7.6.5 Merck & Co. Key News
7.7 AstraZeneca
7.7.1 AstraZeneca Corporate Summary
7.7.2 AstraZeneca Business Overview
7.7.3 AstraZeneca Oncology Drugs Major Product Offerings
7.4.4 AstraZeneca Oncology Drugs Revenue in Global (2016-2021)
7.7.5 AstraZeneca Key News
7.8 Pfizer
7.8.1 Pfizer Corporate Summary
7.8.2 Pfizer Business Overview
7.8.3 Pfizer Oncology Drugs Major Product Offerings
7.8.4 Pfizer Oncology Drugs Revenue in Global (2016-2021)
7.8.5 Pfizer Key News
7.9 Amgen
7.9.1 Amgen Corporate Summary
7.9.2 Amgen Business Overview
7.9.3 Amgen Oncology Drugs Major Product Offerings
7.9.4 Amgen Oncology Drugs Revenue in Global (2016-2021)
7.9.5 Amgen Key News
7.10 Eli Lilly
7.10.1 Eli Lilly Corporate Summary
7.10.2 Eli Lilly Business Overview
7.10.3 Eli Lilly Oncology Drugs Major Product Offerings
7.10.4 Eli Lilly Oncology Drugs Revenue in Global (2016-2021)
7.10.5 Eli Lilly Key News
7.11 AbbVie
7.11.1 AbbVie Corporate Summary
7.11.2 AbbVie Business Overview
7.11.3 AbbVie Oncology Drugs Major Product Offerings
7.11.4 AbbVie Oncology Drugs Revenue in Global (2016-2021)
7.11.5 AbbVie Key News
7.12 Takeda
7.12.1 Takeda Corporate Summary
7.12.2 Takeda Business Overview
7.12.3 Takeda Oncology Drugs Major Product Offerings
7.12.4 Takeda Oncology Drugs Revenue in Global (2016-2021)
7.12.5 Takeda Key News
7.13 Astellas
7.13.1 Astellas Corporate Summary
7.13.2 Astellas Business Overview
7.13.3 Astellas Oncology Drugs Major Product Offerings
7.13.4 Astellas Oncology Drugs Revenue in Global (2016-2021)
7.13.5 Astellas Key News
7.14 Ipsen
7.14.1 Ipsen Corporate Summary
7.14.2 Ipsen Business Overview
7.14.3 Ipsen Oncology Drugs Major Product Offerings
7.14.4 Ipsen Oncology Drugs Revenue in Global (2016-2021)
7.14.5 Ipsen Key News
7.15 Sanofi
7.15.1 Sanofi Corporate Summary
7.15.2 Sanofi Business Overview
7.15.3 Sanofi Oncology Drugs Major Product Offerings
7.15.4 Sanofi Oncology Drugs Revenue in Global (2016-2021)
7.15.5 Sanofi Key News
7.16 Bayer
7.16.1 Bayer Corporate Summary
7.16.2 Bayer Business Overview
7.16.3 Bayer Oncology Drugs Major Product Offerings
7.16.4 Bayer Oncology Drugs Revenue in Global (2016-2021)
7.16.5 Bayer Key News
7.17 Biogen Idec
7.17.1 Biogen Idec Corporate Summary
7.17.2 Biogen Idec Business Overview
7.17.3 Biogen Idec Oncology Drugs Major Product Offerings
7.17.4 Biogen Idec Oncology Drugs Revenue in Global (2016-2021)
7.17.5 Biogen Idec Key News
7.18 Teva
7.18.1 Teva Corporate Summary
7.18.2 Teva Business Overview
7.18.3 Teva Oncology Drugs Major Product Offerings
7.18.4 Teva Oncology Drugs Revenue in Global (2016-2021)
7.18.5 Teva Key News
7.19 Otsuka
7.19.1 Otsuka Corporate Summary
7.19.2 Otsuka Business Overview
7.19.3 Otsuka Oncology Drugs Major Product Offerings
7.19.4 Otsuka Oncology Drugs Revenue in Global (2016-2021)
7.19.5 Otsuka Key News
7.20 Eisai
7.20.1 Eisai Corporate Summary
7.20.2 Eisai Business Overview
7.20.3 Eisai Oncology Drugs Major Product Offerings
7.20.4 Eisai Oncology Drugs Revenue in Global (2016-2021)
7.20.5 Eisai Key News
7.21 Merck KGaA
7.21.1 Merck KGaA Corporate Summary
7.21.2 Merck KGaA Business Overview
7.21.3 Merck KGaA Oncology Drugs Major Product Offerings
7.21.4 Merck KGaA Oncology Drugs Revenue in Global (2016-2021)
7.21.5 Merck KGaA Key News
7.22 Gilead Sciences
7.22.1 Gilead Sciences Corporate Summary
7.22.2 Gilead Sciences Business Overview
7.22.3 Gilead Sciences Oncology Drugs Major Product Offerings
7.22.4 Gilead Sciences Oncology Drugs Revenue in Global (2016-2021)
7.22.5 Gilead Sciences Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
List of Tables
Table 1. Oncology Drugs Market Opportunities & Trends in Global Market
Table 2. Oncology Drugs Market Drivers in Global Market
Table 3. Oncology Drugs Market Restraints in Global Market
Table 4. Key Players of Oncology Drugs in Global Market
Table 5. Top Oncology Drugs Players in Global Market, Ranking by Revenue (2019)
Table 6. Global Oncology Drugs Revenue by Companies, (US$, Mn), 2016-2021
Table 7. Global Oncology Drugs Revenue Share by Companies, 2016-2021
Table 8. Global Companies Oncology Drugs Product Type
Table 9. List of Global Tier 1 Oncology Drugs Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Oncology Drugs Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type